Envestnet Portfolio Solutions’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$519K Sell
8,272
-1,809
-18% -$126K ﹤0.01% 885
2025
Q4
$669K Buy
10,081
+1,207
+14% +$78K ﹤0.01% 929
2025
Q3
$597K Sell
8,874
-2,181
-20% -$173K ﹤0.01% 961
2025
Q2
$965K Sell
11,055
-1,510
-12% -$118K ﹤0.01% 801
2025
Q1
$858K Sell
12,565
-3,594
-22% -$293K ﹤0.01% 845
2024
Q4
$1.26M Buy
16,159
+3,778
+31% +$280K ﹤0.01% 831
2024
Q3
$830K Sell
12,381
-14,887
-55% -$1.22M ﹤0.01% 970
2024
Q2
$3.09M Buy
27,268
+547
+2% +$69.2K 0.01% 503
2024
Q1
$3.71M Buy
26,721
+601
+2% +$75.5K 0.01% 463
2023
Q4
$3.24M Buy
26,120
+1,088
+4% +$111K 0.01% 451
2023
Q3
$2.34M Buy
+25,032
New +$2.82M 0.01% 508

Other funds holding DXCM

Envestnet Portfolio Solutions's DXCM Position: Q1 2026 in Review

Envestnet Portfolio Solutions reduced its DexCom (DXCM) stake by 18% in Q1 2026, selling an estimated $126K and leaving 8,272 shares worth $519K. The position accounts for ﹤0.01% of the portfolio, ranked #885.

Envestnet Portfolio Solutions first reported a position in DXCM in Q3 2023 and has held it in 11 quarters since. The position peaked at $3.71M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Envestnet Portfolio Solutions held 8,272 shares of DexCom worth $519K as of Q1 2026.
  • Envestnet Portfolio Solutions sold 1,809 DexCom shares in Q1 2026, an estimated $126K.
  • DexCom made up ﹤0.01% of Envestnet Portfolio Solutions's portfolio in Q1 2026, its #885 holding.
  • Envestnet Portfolio Solutions first reported a position in DexCom in Q3 2023 and has held it in 11 quarters since.
  • Envestnet Portfolio Solutions's DexCom position peaked at $3.71M in Q1 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q1 2026, filed 29 Apr 2026.